Contributed Papers
Statistical Innovation and Opportunities for Oncology Clinical Trials
Chaoran HuChair
Biopharmaceutical Section
7 Presentations
8:35 AM - 8:50 AM
Co-authors: Zhili Qiao (Eli Lilly and Company), Zhili Qiao (Eli Lilly and Company), Yongming Qu (Eli Lilly and Company)
8:50 AM - 9:05 AM
Co-authors: Binbing Yu (AstraZeneca), Binbing Yu (AstraZeneca), Dai Feng (AbbVie), Laura Fernandes (COTA Healthcare Inc.), Haijun Ma (Exelixis), Philip He (Daiichi Sankyo Inc.), Arunava Chakravartty (Novartis)
9:05 AM - 9:20 AM
Co-authors: Yu-Che Chung (Takeda), Yunqi Zhao, Yu-Che Chung (Takeda), Meizi Liu (Takeda), Jianchang Lin (Takeda), Rachael Liu (Takeda Pharmaceuticals)
9:20 AM - 9:35 AM
Co-authors: Byron Gajewski (University of Kansas Medical Center), Byron Gajewski (University of Kansas Medical Center), Renee Martin (Medical University of South Carolina), Jonathan Beall (Medical University of South Carolina), Christy Cassarly (MUSC), ADNAN QURESHI (University of Missouri), Jose Suarez (Johns Hopkins University)
9:35 AM - 9:50 AM
Co-authors: Philip He (Daiichi Sankyo Inc.), Philip He (Daiichi Sankyo Inc.), Revathi Ananthakrishnan (Bristol-Myers Squibb), Gu Mi (Sanofi), Laura Fernandes (COTA Healthcare Inc.), David Leung (Daiichi Sankyo), Caleb Lee (Daiichi Sankyo), Natalie Ren (iTeos Therapeutics), Sohail Chaudhry (Nektar Therapeutics), Hui Yang (Takeda), Helen Zhou (GSK), Haijun Ma (Exelixis), Cassie Dong
9:50 AM - 10:05 AM
Co-authors: Xiaowei Ren (Novo Nordisk US R&D), Tian Chen (Takeda), Shuli Li (Takeda), Hui Yang (Takeda), Guohui Liu (Takeda Pharmaceuticals International Co.)